Evidence-Based Medicine Guidelines
Temozolomide for high grade glioma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Temozolomide for High Grade Glioma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457734/all/_________Temozolomide_for_high_grade_glioma______.
Temozolomide for high grade glioma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457734/all/_________Temozolomide_for_high_grade_glioma______. Accessed November 4, 2025.
Temozolomide for high grade glioma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457734/all/_________Temozolomide_for_high_grade_glioma______
Temozolomide for High Grade Glioma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 November 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457734/all/_________Temozolomide_for_high_grade_glioma______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Temozolomide for high grade glioma
ID - 457734
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457734/all/_________Temozolomide_for_high_grade_glioma______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
